摘要
缺血修饰白蛋白(ischemia modified albumin,IMA)是近年来发现的新的心肌缺血标志物,具有极高的敏感性,能在心肌缺血的早期阶段检出,有助于心肌缺血的诊断和急性冠脉综合征的危险分层。现简要介绍近年来IMA临床应用的研究进展。
Ischemia modified albumin (IMA), measured by the albumin-cobalt binding test, has been shown to be a novel marker of myocardial ischemia. IMA can be detected at the early stage of myocardial ischemia and can be used to stratify the risk of acute coronary syndromes.
出处
《心血管病学进展》
CAS
2008年第5期788-791,共4页
Advances in Cardiovascular Diseases